Recent Blog Posts

View Post: Kidney disease patients how to select antidiabetic drug ...
3 hours ago by admin  
Kidney damage associated with diabetes mellitus, metformin should not be applied because the drug mainly from urine, easy to accumulate in the body and even cause lactic acidosis. ... Thiazolidine-2 ketone derivatives (rosiglitazone, pioglitazone): rosiglitazone after oral administration, approximately 64% excreted in urine, 23% from feces. The metabolism of pioglitazone product is mainly excreted through the bile, two kinds of drugs in renal insufficiency can be applied. ...
View Blog: Diabetes Disease - http://www.diabetes-disease.com/

---

View Post: Rosiglitazone Associated Fractures in Type 2 Diabetes: An Analysis ...
5 Feb 2008 by Kahn, SE, Zinman, B., Lachin, JM, Haffner,...  
Objective: To examine possible factors associated with the increased risk of fractures observed with rosiglitazone in ADOPT (A Diabetes Outcome Progression Trial). Research Design and Methods: Data from the 1840 women and 2511 men ...
View Blog: Diabetes Care Journal publish ahead of... - http://care.diabetesjournals.org/

---

View Post: dave.md: Results from the ADOPT Study
4 Dec 2006
In recently-diagnosed type 2 diabetes, initial monotherapy with rosiglitazone (Avandia® , GlaxoSmithKline) is associated with a significantly slower progression of monotherapy failure compared to metformin (Glucophage®, Bristol-Myers ...
View Blog: dave.md: Diabetes And Vascular Education:... - http://dave.md/

---

View Post: Diabetes drug linked to heart failure
Better Life, Better Health ...
12 Nov 2009 by David Morton   ...
View Blog: http://betterspines.com/

---

View Post: How Avandia Treats Type 2 Diabetes
19 Nov 2009 by Foods Union  
Avandia is the trade name of the pharmaceuticals company GlaxoSmithKline for the generic drug Rosiglitazone. Rosiglitazone is often termed an insulin sensitizer because it attaches to insulin receptors on cells (the peroxisome ...
View Blog: Foods Union - http://foodsunion.com/

---

View Post: “Agonizing” over Diabetes and Weight Gain — JBC
23 Oct 2009
“Agonizing” over Diabetes and Weight Gain♦. Peroxisome Proliferator-activated Receptor γ Agonist Rosiglitazone Increases Expression of Very Low Density Lipoprotein Receptor Gene in Adipocytes. ♦ See referenced article, J. Biol. Chem. ...
View Blog: Journal of Biological Chemistry current issue - http://www.jbc.org/

---

View Post: Rosiglitazone Delays Treatment Failure in Patients with Type 2 ...
6 Dec 2006
In the current study by Kahn and colleagues comparing rosiglitazone, metformin, and glyburide monotherapy for the treatment of type 2 diabetes, rosiglitazone was superior to the other 2 medication in all of the following outcomes except ...
View Blog: Medscape Internal Medicine Headlines - http://www.medscape.com/internalmedicine

---

View Post: Diabetes drugs increase heart failure risk
News
Nursing Times ...
View Blog: “This is a well-designed retrospective study of older people with Type 2 diabetes using rosiglitazone or pioglitazone. Both drugs carry an increased risk of heart failure. The findings confirm previous results of other studies showing

---

View Post: Byetta gains expanded indication for first-line treatment for type ...
2 Nov 2009
The FDA has approved Byetta (exenatide injection, from Amylin and Lilly), a GLP-1 receptor agonist, for use as monotherapy along with diet and exercise to improve glycemic control in adults with type 2 diabetes. ... AVANDARYL 4mg/1mg. Endocrine System > Diabetes. Rosiglitazone (as maleate) 4mg, glimepiride 1mg; tabs. ...
View Blog: Latest articles from MPR - http://www.empr.com/

---